BBIO vs KO · rev $221.9M vs P/E 25, rev $47.94B
BridgeBio Pharma Inc (BBIO) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
BBIO currently screens at market cap $13.24B. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the BBIO and KO stock pages for the full models.
Not investment advice.